Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 4:41 pm Unchanged | 13G | CLENE INC WT EXP 11/07/25 CLNNW | Walton Thomas Layton | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-14 4:13 pm Sale | 13G | Tenaya Therapeutics Inc. TNYA | Walton Thomas Layton | 0 0.000% | -3,759,599 (Position Closed) | View |
| 2022-02-14 4:09 pm Sale | 13G | BIOMX INC PHGE | Walton Thomas Layton | 0 0.000% | -5,512,846 (Position Closed) | View |
| 2022-02-14 4:02 pm Sale | 13G | Tenaya Therapeutics Inc. TNYA | Walton Thomas Layton | 0 0.000% | -2,642,285 (Position Closed) | View |
| 2022-02-14 3:59 pm Sale | 13G | FINCH THERAPEUTICS GROUP INC C FNCH | Walton Thomas Layton | 0 0.000% | -3,487,168 (Position Closed) | View |
| 2021-08-09 5:12 pm Purchase | 13G | Tenaya Therapeutics Inc. TNYA | Walton Thomas Layton | 2,642,285 6.760% | 2,642,285 (New Position) | View |
| 2021-08-09 4:27 pm Purchase | 13G | BIOMX INC PHGE | Walton Thomas Layton | 5,512,846 17.800% | 5,512,846 (New Position) | View |
| 2021-03-26 4:47 pm Purchase | 13G | FINCH THERAPEUTICS GROUP INC C FNCH | Walton Thomas Layton | 3,487,168 7.400% | 3,487,168 (New Position) | View |
| 2021-01-15 3:40 pm Purchase | 13G | CLENE INC WT EXP 11/07/25 CLNNW | Walton Thomas Layton | 3,759,599 6.300% | 3,759,599 (New Position) | View |